Skip to main content
Timothy Pardee, MD, Oncology, Winston Salem, NC

Timothy Pardee MD PhD

Oncology•Winston Salem, NC

Hematologic Oncology

Associate Professor, Internal Medicine, Wake Forest University School of Medicine

Join to View Full Profile

  • 1 S Hawthorne Rd# HanesWinston Salem, NC 27157

  • Phone+1 336-716-5847

  • Fax+1 336-716-2067

Dr. Pardee is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Pardee's Full ProfileAlready have an account?

Education & Training

  • Stony Brook Medicine/University Hospital
    Stony Brook Medicine/University HospitalFellowship, Hematology and Medical Oncology, 2005 - 2009
  • Mass General Brigham/Massachusetts General Hospital
    Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 2003 - 2005
  • Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo
    Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2003

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 2009 - 2025
  • NY State Medical License
    NY State Medical License 2005 - 2010
  • Hematology
    American Board of Internal Medicine Hematology
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2012

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • A Phase II Clinical Trial of Cpi-613 (devimistat) in Patients with Relapsed or Refractory Burkitt Lymphoma/Leukemia or High-Grade B-Cell Lymphoma with Rearrangements o...
    Timothy S. Pardee, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Evaluating the Utilization of All-Trans Retinoic Acid and Arsenic Trioxide during Consolidation Therapy for Patients Receiving Treatment for Acute Promyelocytic Leukemia
    Timothy S. Pardee, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • Multicentre, Open Label, Randomized Phase III Study of Cpi-613¬ (devimistat) in Combination with High Dose Cytarabine and Mitoxantrone (CHAM) Compared to High Dose Cyt... 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Selinexor in Combination with Induction and Consolidation Therapy in Older Adults with AML Is Highly ActiveClinically Relevant Abstract 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Press Mentions

  • Rafael Pharmaceuticals to Present New Data Validating Efficacy and Tolerability of CPI-613 in Treating Acute Myeloid Leukemia at the 23rd Congress of the European Hematology Association
    Rafael Pharmaceuticals to Present New Data Validating Efficacy and Tolerability of CPI-613 in Treating Acute Myeloid Leukemia at the 23rd Congress of the European Hematology AssociationJune 16th, 2018
  • WFIRM Scientists Study Space Radiation Health Effects to Keep Astronauts Safe
    WFIRM Scientists Study Space Radiation Health Effects to Keep Astronauts SafeNovember 14th, 2017
  • Pappas Capital and Wake Forest Innovations Announce First Investments by the Catalyst Fund
    Pappas Capital and Wake Forest Innovations Announce First Investments by the Catalyst FundJanuary 11th, 2017
  • Join now to see all

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Timothy Pardee, Dr. Timothy Pardee, MD, Dr. T Pardee